Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PMN

PMN - ProMIS Neurosciences, Inc. Stock Price, Fair Value and News

$11.80+1.14 (+10.69%)
Market Closed

Price Targets

PMN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PMN Price Action

Last 7 days

43.0%

Last 30 days

60.1%

Last 90 days

12.4%

Trailing 12 Months

-46.4%

PMN RSI Chart

PMN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PMN Valuation

Market Cap

635.0M

Price/Earnings (Trailing)

-21.68

Price/Free Cashflow

-23.05

PMN Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

PMN Fundamentals

PMN Earnings

Earnings (TTM)

-29.3M

Earnings Growth (Yr)

-224.84%

Earnings Growth (Qtr)

-14.46%

PMN Profitability

Return on Equity

-318.73%

Return on Assets

-136.47%

Free Cashflow Yield

-4.34%

PMN Investor Care

Shares Dilution (1Y)

64.61%

Diluted EPS (TTM)

-0.69

About ProMIS Neurosciences, Inc.

PMN
ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
 CEO
 WEBSITEpromisneurosciences.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES6

ProMIS Neurosciences, Inc. Frequently Asked Questions

PMN is the stock ticker symbol of ProMIS Neurosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of ProMIS Neurosciences, Inc. is 634.97 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PMN's fair value in chart for subscribers.

The fair value guage provides a quick view whether PMN is over valued or under valued. Whether ProMIS Neurosciences, Inc. is cheap or expensive depends on the assumptions which impact ProMIS Neurosciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PMN.

In the past 10 years, ProMIS Neurosciences, Inc. has provided -0.169 (multiply by 100 for percentage) rate of return.